The health minister of Panama has said that the country will offer a third COVID-19 vaccine dose to moderate and severely immunocompromised people starting this week, Reuters news agency reported on Wednesday.
Luis Sucre was quoted as saying on Tuesday: "The additional dose aims to improve the immune response" of immunosuppressed patients.
He explained that the campaign would be carried out in national and regional hospitals in the country.
Among those eligible to get an extra shot during the first phase of this plan are people undergoing cancer treatment and transplants, as well as those who received stem cells in the last two years or suffer from an advanced or untreated HIV infection.
So far, Panama has administered 5.3 million doses of COVID-19 vaccine and authorities say the county is close to herd immunity.
Relay Therapeutics wins FDA breakthrough status for zovegalisib in breast cancer treatment
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
Lupin launches Dasatinib tablets in US market
WuXi Biologics enters into licence and research service agreement with Vertex Pharmaceuticals
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer
I Peace generates human iPS cells from NKT cells and offers them for research use
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat
Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA